What Smartox does

Smartox is a privately held provider of drug and alcohol testing products, laboratory confirmation services, and program management solutions, headquartered at 4850 Plaza Dr in Irving, Texas, and operating since 2012. The company addresses drug screening across five specimen modalities — urine, oral fluid, sweat (patch), fingerprint sweat, and breath — under its SmarTest brand family (Patch, Touch, Saliva, Cup, Dip), supplemented by the licensed Intelligent Fingerprinting platform and a Personal Breath Tester using European fuel cell technology. Core detection relies on immunoassay lateral flow for presumptive screening with LC/MS/MS confirmation performed at CAP/CLIA-certified partner laboratories; flagship CLIA-waived / FDA 510(k)-cleared products include the 16-panel SmarTest Cup and the 15-panel SmarTest Dip, while the SmarTest Patch (a 7–10 day wearable sweat patch detecting 11+ drugs including fentanyl) and SmarTest Touch (a patented touch-collection cartridge processed via LC/MS/MS) represent newer continuous-monitoring and gender-neutral collection capabilities.

The business model blends three revenue streams: (1) hardware sales of consumable test devices and instruments through a direct e-commerce storefront (shop.smartox.com) and bulk purchase orders, (2) professional lab confirmation services routed to certified partner labs, and (3) managed services including Third-Party Administrator (TPA) program management, MRO support, random selection, and DOT compliance for enterprise clients. Pricing is quote-based and not publicly disclosed, with multi-year contracts typical for institutional customers. Go-to-market combines direct enterprise sales (targeting law enforcement, probation/courts, drug rehabilitation, schools, workplaces, and clinics/hospitals), self-serve e-commerce for SMB and individual buyers, and a global distribution partnership with Intelligent Bio Solutions — covering the U.S. Forensic Use Only market since 2025 and international markets outside the U.S./Canada from July 2025 onward for the SmarTest Patch.

Operationally, Smartox maintains 250,000+ devices in stock across 50+ product configurations and runs a nationwide collection network for lab testing services, while operating with a 1–10 employee footprint. The company is privately held with no disclosed funding rounds, ownership structure, or management team bios available in the source data, and partnerships — particularly with Intelligent Bio Solutions — represent both a core growth lever and a notable concentration dependency.

Name

Smartox

Legal name

Smartox

Website

https://smartox.com

Company type

Private

Founded year

2012

Operating status

Operating

Headcount range

1–10 employees

Short description

Smartox is a privately held Irving, Texas-based provider of drug and alcohol testing products, lab confirmation services, and program management solutions serving law enforcement, courts, rehabilitation centers, schools, and workplaces across multiple specimen modalities.

Ownership category

akta.pro rank

Product category

Drug Testing Products and Laboratory Services

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413), Analytical Laboratory Instrument Manufacturing (334516), Medical Laboratories (621511), Testing Laboratories and Services (54138)

SIC

In Vitro & In Vivo Diagnostic Substances (2835), Services-Medical Laboratories (8071), Laboratory Analytical Instruments (3826), Services-Testing Laboratories (8734)

akta.pro primary industry

Home-Use & OTC Rapid Self-Tests (Consumer POCT kits) (HLAHAOAK)

akta.pro secondary industry

Home Diagnostic & Self-Test OTC Kits (HLAIADAO)

Keywords

• Drug testing products
• Laboratory confirmation services
• Workplace drug screening
• Alcohol testing supplies
• Program management services

Headquarters

HQ city

Irving

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Drug Testing Products (Hardware Sales): Smartox sells drug testing hardware including urine cups, dip cards, oral fluid tests, breathalyzers, fingerprint-based screening devices, and the SmarTest Patch. Products are sold as one-time purchases (per-unit) with per-unit pricing. Over 250,000 devices are kept in stock, suggesting a significant inventory-based distribution model.
2. Lab Confirmation Services: Smartox provides laboratory confirmation testing at certified laboratories using urine, oral fluid, and sweat specimens. LC/MS/MS technology is used for confirmation. These services are offered alongside product sales as an integrated service offering.
3. Third-Party Administrator (TPA) Services: Smartox offers complete TPA services for managing drug-testing programs, including pre-employment, post-accident, and random drug testing programs. This is a managed service offering for corporate and institutional customers.
4. Program Management Services: Smartox provides program management services for companies and schools, including software for roster management, result reporting, random selection, and MRO support. Services include nationwide collection network coordination and customizable testing panels.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

Core offering

Smartox manufactures, distributes, and retails drug and alcohol testing products including urine cups, dip cards, oral fluid tests, breathalyzers, fingerprint-based screening devices, and the SmarTest Patch sweat-based continuous-monitoring patch. It also operates CAP/CLIA-certified laboratories for LC/MS/MS confirmation testing and delivers third-party administrator (TPA) and program management services covering pre-employment, post-accident, and random testing programs.

Product overview

Smartox is a comprehensive drug testing solutions provider offering a portfolio of testing products and services. The core product lineup includes the SmarTest Patch (wearable sweat-based detection), SmarTest Urine Testing Products (cups and dip cards), Intelligent Fingerprinting (fingerprint-based screening), Personal Breath Tester, SmarTest Saliva (oral fluid testing), and SmarTest Touch (touch-based lab service). Supporting services include lab confirmation services and program management. The products range from CLIA-waived OTC cleared tests to Forensic Use Only devices, serving markets including law enforcement, probation/courts, jails, drug rehabilitation, schools, and workplace testing.

Differentiator

Problem solved

Functional benefit

Products and services

• SmarTest Patch A wearable sweat-based drug detection patch adhered to the skin for 7-10 days that continuously collects perspiration for drug testing. Water-resistant, tamper-resistant, and discreet; detects cocaine, opiates, methamphetamines, marijuana, fentanyl, and other drugs. Intended for law enforcement, probation, rehabilitation, and international partners.
• SmarTest Cup Integrated cup urine drug test with 16 CLIA-waived and OTC-cleared tests including AMP, BAR, BUP, BZO, COC, EDDP, MDMA, MET, MOR, MTD, OPI, OXY, PCP, PPX, TCA, THC. Features SAMHSA low cutoffs and differentiated results. Sold to law enforcement, workplaces, and clinics.
• SmarTest Dip Dip card urine drug test with 15 CLIA-waived and OTC-cleared tests, anti-flooding design, 5-60 minute read window, and clearly differentiated results at ±50% cutoff. Sold to workplaces, schools, law enforcement, and clinics.
• Intelligent Fingerprinting Drug Screening Fingerprint sweat-based drug screening using a reader and collection cartridges to detect drug metabolites in under 10 minutes at picogram-level sensitivity (10-100 pg range). Screens for methamphetamine, marijuana, cocaine, opiates, methadone, benzodiazepines, and buprenorphine. Marketed as a Forensic Use Only device.
• Personal Breath Tester DOT/NHTSA-compliant breath alcohol screening device using European fuel cell technology with one-touch operation, deep-lung breath capture, and a color-changing LCD display that signals when BrAC exceeds 0.05%. Sold to workplaces and consumers for alcohol screening.
• SmarTest Saliva (Oral Fluid) Test Oral fluid drug test with 15 drug assays (ALC, AMP, BAR, BUP, BZO, COC, MDMA, KET, MET, MTD, OPI, OXY, PCP, THC) and a built-in saturation indicator that turns red when sufficient sample has been collected. Includes a flip-top lid for secure shipment. Sold to workplaces, schools, and clinics.
• SmarTest Touch Lab Service Touch-based drug testing service using a patented collection cartridge; donor cleans hands and touches the cartridge, which is then sent to a CAP/CLIA-certified lab for LC/MS/MS analysis. Gender-neutral and eliminates observed collections. Sold to workplaces, clinics, and rehabilitation providers.
• Lab Confirmation Services Confirmation testing at CAP/CLIA-certified laboratories using LC/MS/MS technology on urine, oral fluid, and sweat specimens, bundled with Third-Party Administrator (TPA) services for managing pre-employment, post-accident, and random drug testing programs. Sold to corporate, institutional, and government customers.
• Program Management Services Comprehensive drug and alcohol testing program management for companies and schools, including program management software for roster management, result reporting, random selection, MRO support, DOT compliance, customizable panels, and nationwide collection network access.
• Healgen COVID-19 / Flu A&B Combo Test Emergency Use Authorized combo test for COVID-19 and Influenza A&B for use in CLIA-certified laboratories at point of care settings.

Quantifiable outcome

• Results under 10 minutes for Intelligent Fingerprinting drug screening
• +4 more outcomes

Named customers1 record

Segments7 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Two partnerships are on record, tiered core.

• Intelligent Bio Solutions Inc.coreChannel Partner/ Reseller/ Distributor · 16 July 2025Intelligent Bio Solutions Inc. entered into a global distribution agreement with Smartox to bring its SmarTest Patch sweat-based drug detection product to international markets outside the U.S. and Canada. The SmarTest Patch is a discreet, water-resistant wearable device worn for 7-10 days that continuously collects sweat to detect cocaine, opiates, methamphetamines, marijuana, and fentanyl. The agreement strengthens Intelligent Bio's position in noninvasive drug testing solutions and opens opportunities in justice and rehabilitation sectors, with the global drug testing market projected to reach $18.6 billion by 2030.
• Intelligent Bio Solutions Inc.coreTechnology or Integration · 11 June 2025Smartox serves as a strategic partner for Intelligent Bio Solutions in the U.S. Forensic Use Only market. Smartox has deployed over 50 Intelligent Fingerprinting Drug Screening Readers and facilitated over 7,000 screening tests since inception. Intelligent Bio Solutions is actively pursuing FDA clearance for its opiate test system for codeine to enable expansion into broader U.S. markets including workplace drug testing.

Scale indicators5 records

Recent moves1 record

Expansion highlights5 records

Broad incumbents

• Quest Diagnostics: Largest U.S. clinical and workplace drug-testing laboratory, operating a nationwide collection network and broad employer health services. Comparable to Smartox as the dominant end-to-end lab + program management provider Smartox competes against for enterprise and government contracts.
• Laboratory Corporation of America (LabCorp): Major national clinical laboratory offering employer drug-testing services, DOT collections, and confirmation testing. Directly comparable on the lab-confirmation, collection-network, and program-management side of Smartox's offering.
• Abbott: Global diagnostics manufacturer with rapid toxicology products (e.g., SoToxa oral fluid system). Comparable to Smartox on the rapid drug-screening instrument and consumable side, particularly for oral fluid and point-of-care workplace testing.

Direct peers

• Psychemedics Corporation: Hair-based drug-testing laboratory serving workplace and forensic customers. Comparable as a non-urine alternative-modality drug-testing provider targeting similar employer, court, and school customers.
• OraSure Technologies: Developer and manufacturer of the Intercept oral fluid drug-testing device, a direct competitor to Smartox's SmarTest Saliva line. Comparable on modality (oral fluid), customer base (workplace, criminal justice), and FDA-cleared rapid-test positioning.
• Confirm BioSciences: Distributor of rapid drug-testing cups, dip cards, and saliva devices to the workplace, clinical, and at-home markets. Comparable as a multi-modality rapid-test distributor competing for the same SMB and institutional drug-test purchasing channels.
• American Bio Medica Corporation: Developer of the Rapid Drug Screen and other point-of-care urine drug-testing products. Comparable as a small public competitor in the rapid presumptive drug-test market targeting workplace, government, and criminal justice buyers.
• Premier Biotech: Manufacturer and distributor of rapid urine and oral fluid drug-testing cups, dip cards, and related supplies. Comparable as a small-to-mid-market competitor selling similar CLIA-waived drug-test consumables through distribution channels.
• Drägerwerk: Manufacturer of the Dräger Alcotest line of DOT/NHTSA-compliant evidential and screening breath alcohol devices. Comparable as a supplier of the same DOT-compliant breath-testing hardware Smartox bundles with its drug-testing offering.
• Intelligent Bio Solutions Inc. Developer of the Intelligent Fingerprinting system and SmarTest Patch distribution partner. Comparable as the licensor of Smartox's core fingerprint technology and as a direct competitor offering the same sweat-based and rapid drug-screening modalities to law enforcement and rehabilitation markets.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/smartox-llc

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Smartox